piracetam has been researched along with Catatonia in 4 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Catatonia: A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994)
| Excerpt | Relevance | Reference |
|---|---|---|
| " valproate) were studied in rats against perphenazine-induced catatonia." | 7.67 | GABAergic, dopaminergic and cholinergic interactions in perphenazine-induced catatonia in rats. ( Garg, SK; Kulkarni, SK; Mathur, VS; Shukla, VK, 1985) |
| "Levetiracetam (Keppra) is a novel antiepileptic drug approved as adjunctive treatment for adults with partial onset seizures." | 5.33 | Catatonia induced by levetiracetam. ( Bruneau, MA; Chouinard, MJ; Clément, JF; Nguyen, DK, 2006) |
| " He improved rapidly on levetiracetam and lorazepam, was discharged and received a diagnosis of dementia by his community mental health team shortly afterwards, based on chronic short-term memory loss, functional decline and MRI changes." | 3.85 | Intermittent catatonia and complex automatisms caused by frontal lobe epilepsy in dementia. ( George, R; Langford, A, 2017) |
| " valproate) were studied in rats against perphenazine-induced catatonia." | 3.67 | GABAergic, dopaminergic and cholinergic interactions in perphenazine-induced catatonia in rats. ( Garg, SK; Kulkarni, SK; Mathur, VS; Shukla, VK, 1985) |
| "Levetiracetam (Keppra) is a novel antiepileptic drug approved as adjunctive treatment for adults with partial onset seizures." | 1.33 | Catatonia induced by levetiracetam. ( Bruneau, MA; Chouinard, MJ; Clément, JF; Nguyen, DK, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| George, R | 1 |
| Langford, A | 1 |
| Malur, C | 1 |
| Clark, A | 1 |
| Chouinard, MJ | 1 |
| Nguyen, DK | 1 |
| Clément, JF | 1 |
| Bruneau, MA | 1 |
| Shukla, VK | 1 |
| Garg, SK | 1 |
| Mathur, VS | 1 |
| Kulkarni, SK | 1 |
4 other studies available for piracetam and Catatonia
| Article | Year |
|---|---|
Intermittent catatonia and complex automatisms caused by frontal lobe epilepsy in dementia.
Topics: Aged, 80 and over; Anticonvulsants; Automatism; Catatonia; Dementia; Diagnosis, Differential; Electr | 2017 |
Catatonia after right temporal lobe resection.
Topics: Adult; Anticonvulsants; Catatonia; Epilepsy, Temporal Lobe; Humans; Levetiracetam; Lorazepam; Male; | 2010 |
Catatonia induced by levetiracetam.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Catatonia; Drug Therapy, Combination; Epilepsies, Part | 2006 |
GABAergic, dopaminergic and cholinergic interactions in perphenazine-induced catatonia in rats.
Topics: Animals; Bromocriptine; Catatonia; Dopamine; Drug Synergism; GABA Antagonists; gamma-Aminobutyric Ac | 1985 |